Arm's 1.29% Gain Ranks 224th on Global Volume Amid Malaysia's $1.1B Chip Pact and MACC Probe

Market Snapshot

On February 17, 2026, Arm Holdings (ARM) closed with a 1.29% increase, marking a modest gain in a day where the stock ranked 224th in trading volume across global markets. The company’s shares saw a turnover of $0.53 billion, reflecting moderate investor activity. While the percentage rise was relatively modest, the stock’s performance aligns with broader market trends where semiconductor equities have shown resilience amid macroeconomic uncertainties. The upward movement appears to be driven by a combination of strategic corporate developments and evolving regulatory scrutiny, as detailed in recent news reports.

Key Drivers

The RM1.1 billion semiconductor partnership between Malaysia and Arm Holdings, signed in March 2025, has emerged as a central topic of discussion. The deal aims to secure advanced chip design intellectual property from Arm, with the Malaysian government seeking to transition its semiconductor industry from low-value assembly and testing to high-end design and innovation. This strategic pivot aligns with global trends in semiconductor manufacturing and positions Malaysia to capitalize on the artificial intelligence-driven demand for next-generation chips. The collaboration has been framed as a long-term economic bet, with Arm’s technology serving as a critical enabler for Malaysia’s industrial modernization.

However, the agreement has drawn scrutiny from Malaysia’s Anti-Corruption Commission (MACC), which is investigating whether the deal received proper approvals from the Ministry of Investment, Trade and Industry (Miti) and the Ministry of Finance (MOF). Former Economy Minister Rafizi Ramli has defended the process, stating that the proposal was presented to the Cabinet three times and negotiated by an inter-ministerial committee comprising officials from Miti, MOF, and the Ministry of Economy. He emphasized that the Prime Minister, Anwar Ibrahim, personally oversaw the finalization of the deal to honor a previously agreed signing date with Arm. The involvement of high-profile stakeholders, including Arm’s leadership and SoftBank’s Masayoshi Son, further underscores the complexity and significance of the agreement.

The political and procedural nuances of the deal have introduced volatility into Arm’s stock. While the Malaysian government asserts that the collaboration was rigorously vetted, the MACC investigation raises questions about governance practices and potential conflicts of interest. Rafizi’s assertion that the deal was not “rushed” and involved multiple layers of oversight—such as Cabinet approvals and Attorney General’s Chamber vetting—aims to reassure investors. However, the probe could create reputational risks for Arm and its partners, particularly if regulatory findings suggest procedural lapses. The stock’s 1.29% gain on the day may reflect investor optimism about the strategic value of the partnership, despite lingering uncertainties.

A key factor influencing market sentiment is the broader geopolitical context. Malaysia’s semiconductor ambitions align with global efforts to diversify supply chains away from China, a trend that has bolstered demand for Arm’s IP in regions like Southeast Asia. The RM1.1 billion deal is part of this larger narrative, with Arm positioned as a beneficiary of increased investment in semiconductor innovation. Meanwhile, the investigation highlights the challenges of executing large-scale cross-border partnerships in politically sensitive environments. Investors appear to be weighing the long-term strategic benefits of the collaboration against short-term risks tied to regulatory and political developments in Malaysia.

The interplay between these factors has created a mixed outlook for Arm’s stock. On one hand, the partnership with Malaysia represents a significant market expansion opportunity, particularly in the AI and high-performance computing sectors. On the other, the MACC probe introduces uncertainty about the deal’s compliance with local governance standards. The stock’s moderate gain suggests that investors are cautiously optimistic, viewing the strategic value of the collaboration as a more compelling driver than immediate regulatory concerns. However, any escalation in the investigation or adverse findings could trigger a reassessment of the partnership’s risks and potentially impact Arm’s valuation.

In conclusion, Arm’s recent performance reflects a balance between strategic growth opportunities and regulatory headwinds. The RM1.1 billion deal with Malaysia underscores the company’s role in enabling the next phase of semiconductor innovation, while the MACC investigation highlights the complexities of navigating high-stakes international partnerships. As the situation evolves, investors will likely monitor both the progress of the collaboration and the outcome of the regulatory scrutiny, with potential implications for Arm’s market position and stock trajectory.